Spryte Medical
MA - BedfordBiotechnology
Focus: Spryte Medical is a pre-revenue biotech company focused on neuro intravascular imaging agents for cardiovascular applications, specifically intracranial aneurysm treatment. The company is early-stage with minimal public footprint and limited disclosed operational scale.
Profile data last refreshed 17h ago · AI intelligence enriched 2w ago
Open Jobs
0
About Spryte Medical
AI assessmentNot HiringNo open roles listed right now. Follow Spryte Medical to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Endovascular Intracranial aneurysm treatment
Intracranial AneurysmClinical Trials (1)
NCT07214220Intravascular Neuro OCT Imaging System for Aneurysm Treatment Evaluation
N/AHelp build intelligence for Spryte Medical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.